2Miao Q, Liu Q, Wang C, et al. Inhibitory effect of la,25-dihydroxyvitamin D3 on excretion of JBP485 via organic anion transporters in rats[J]. Eur J Pharm Sci, 2013,48(1-2):351-359.
3Zolk O, Solbach TF, K6nig J, et al. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser[J]. Drug M etab Dispos, 2009,37(6): 1312-1318.
4Inui KI, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney[J]. Kidney Int, 2000,58(3):944-958.
5Schinkel AH, Jonker JW. Mammalian drug effiux transporters of the ATP binding cassette (ABC) family: an overview[J]. Adv Drug Deliv Rev, 2003, 55(1):3-29.
6Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge[J]. J Pharmacol Sci, 2006, 100(5):411-426.
7Guo X, Meng Q, Liu Q, et al. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2[J]. Peptides, 2012, 34(2):395-403.
8Sekine T, Watanabe N, Hosoyamada M, et al. Expression cloning and characterization of a novel multispecific organic anion transporter[J]. J Biol Chem, 1997, 272(30):18526-18529.
9Zhu Y, Meng Q, Wang C, et al. Organic anion transporters involved in the excretion of bestatin in the kidney[J]. Peptides, 2012, 33(2):265-271.
10Ye J, Liu Q, Wang C, et al. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3[J]. Eur J Pharm Sci, 2012, 47(2):341-346.
